Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06610474 · ClinicalTrials.gov registry record · NA
Evaluation of an Online Prostate Cancer Screening Decision Aid
A NA study of Prostate Cancer, sponsored by David Siegel.
- Recruiting
- Registry status
- NA
- Development phase
- 510
- Enrollment target
- 4
- Study locations
NCT06610474: Recruiting NA study of Prostate Cancer, sponsored by David Siegel.
NCT06610474 is a NA study of Prostate Cancer that is actively recruiting participants, run by David Siegel. The registered enrollment target is 510 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (16% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06610474, a NA study of Prostate Cancer, is actively recruiting participants, sponsored by David Siegel.
- RECRUITING
- Registry status
- NA
- Development phase
- 510 participants
- Enrollment target
- 4
- Study locations
Study Summary
The goal of this clinical trial is to learn if the online, simulated human "Talk to Nathan About Prostate Cancer Screening" decision aid (https://www.cdc.gov/prostate-cancer/talk-to-nathan/index.html) is effective in helping patients decide about prostate cancer screening. The main questions it aims to answer are: * Is using the "Talk to Nathan About Prostate Cancer Screening" decision aid effective in improving knowledge, overcoming health literacy barriers, and resolving decisional conflict compared to a standard decision aid or standard education materials? * What are the barriers and best practices for incorporating Talk to Nathan About Prostate Cancer Screening into the flow of primary care practice? Researchers will compare "Talk to Nathan About Prostate Cancer Screening" to a standard decision aid and to standard prostate cancer screening education materials to test the effectiveness of using "Talk to Nathan About Prostate Cancer Screening." Participants will: * Use "Talk to Nathan About Prostate Cancer Screening," use a standard decision aid, or use standard education materials about prostate cancer screening * Visit the primary care clinic for follow-up * Complete surveys as part of the clinical trial
Primary Outcome
Assessment by participant survey
Conditions Studied
Interventions
- BEHAVIORAL Use of the online "Talk to Nathan about Prostate Cancer" decision aid
- BEHAVIORAL Use of a standard prostate cancer screening decision aid
- BEHAVIORAL Use of standard prostate cancer education materials
Study Locations (4)
North Carolina
- Camino - Charlotte
- Alliance Medical Ministry - Raleigh
New York
- East Northport Medical Care - East Northport
South Carolina
- Clemson Rural Health - Clemson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 510 participants |
| Start Date | 2024-11-27 |
| Est. Completion | 2026-01 |
| Phase | NA |
What NCT06610474 shows while recruiting
NCT06610474 is an interventional study that assigns participants to a tested intervention. The registered 510 participants enrollment target is mid-sized for trials with a published cap, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (16% lower).
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 3 interventions - of which Use of the online "Talk to Nathan about Prostate Cancer" decision aid is the first listed.
NCT06610474 reports a single indexed study location in North Carolina, New York, South Carolina.
Frequently Asked Questions
What is clinical trial NCT06610474 about?
NCT06610474 is a clinical study titled "Evaluation of an Online Prostate Cancer Screening Decision Aid". The goal of this clinical trial is to learn if the online, simulated human "Talk to Nathan About Prostate Cancer Screening" decision aid (https://www.cdc.gov/prostate-cancer/talk-to-nathan/index.html) is effective in helping patients decide about prostate cancer screening. The main questions it aims...
What is the current status of trial NCT06610474?
This trial is currently recruiting. It is a NA study. The enrollment target is 510 participants. The study started on 2024-11-27. Estimated completion is 2026-01.
What conditions does trial NCT06610474 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT06610474?
The interventions under investigation include: Use of the online "Talk to Nathan about Prostate Cancer" decision aid (BEHAVIORAL), Use of a standard prostate cancer screening decision aid (BEHAVIORAL), Use of standard prostate cancer education materials (BEHAVIORAL).
Who is sponsoring clinical trial NCT06610474?
This trial is sponsored by David Siegel, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06610474 being conducted?
This trial has 4 study locations across New York, North Carolina, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06610474's enrollment target sits among peer trials
510 103rd of 735 higher than 633 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03922542 · 510 participants · Phase 2
Comparison of Standard vs. Accelerated Corneal Crosslinking
- NCT04634552 · 510 participants · Phase 2
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
- NCT05164744 · 510 participants
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
- NCT05451004 · 510 participants · Phase 3
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI